What does CUSIP G2161P132 represent in this 13F holders report?

CUSIP G2161P132 is the security identifier for SXTC - CHINA SXT PHARMACEUTICALS IN - SHS NEW used to aggregate holder disclosures.

How many institutions held SXTC - CHINA SXT PHARMACEUTICALS IN - SHS NEW in Q3 2023?

8 institutional investors reported SXTC - CHINA SXT PHARMACEUTICALS IN - SHS NEW for Q3 2023. Use the holders table for investor-level position and value details.

CHINA SXT PHARMACEUTICALS IN - SHS NEW (SXTC)

CUSIP: G2161P132

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / SHS NEW
Total 13F shares: 480,457
Total 13F value: $57,037
Share change: +333,899
SEC-reported price per share: $0.12
Number of holders: 8
Value change: +$38,060
Number of buys: 7
Number of sells: 2

Security key

G2161P132

Report period

Q3 2023

Institutions

Top holders

SXTC full security history Ownership snapshot Full 13F holder table China SXT Pharmaceuticals, Inc. SEC filings China SXT Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SXTC - CHINA SXT PHARMACEUTICALS IN - SHS NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ACADIAN ASSET MANAGEMENT LLC

Disclosed value leader

ACADIAN ASSET MANAGEMENT LLC

Comparable rows

0/5

Latest evidence

30 Jun 2023

13F 3/4/5 Highest disclosed value: $23,000 5 rows are not safely comparable across share classes.

Quick read

ACADIAN ASSET MANAGEMENT LLC has the largest disclosed position value at $23K.

0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ACADIAN ASSET MANAGEMENT LLC's linked filing trail.

Disclosed position value Top 4

ACADIAN ASSET MANAGEMENT LLC $23K

TWO SIGMA SECURITIES, LLC $4.8K

Cetera Advisor Networks LLC $2.4K

RENAISSANCE TECHNOLOGIES LLC $2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-5 of 5 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	— denominator unverified	$23,000 105,039 shares	—	30 Jun 2023
TWO SIGMA SECURITIES, LLC	13F Company 13F	— denominator unverified	$4,833 20,564 shares	—	30 Jun 2023
Cetera Advisor Networks LLC	13F Company 13F	— denominator unverified	$2,448 10,415 shares	—	30 Jun 2023
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$2,000 10,540 shares	—	30 Jun 2023
Feng Felix Zhou	3/4/5 Co-CEO and Director, Director 3/4/5	— denominator unverified	— 4 shares	—	04 Jul 2017

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

480,457

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders

Q3 2023 holders

Holder diff

Investor	Q2 2023 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2023 value	Q3 2023 value	Value change	Value Chg %